LOS ANGELES, September 30, 2025 — Leads & Copy — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) has successfully closed its strategic investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN), totaling approximately $41 million. FF led with about $30 million, with an additional $4 million from FF Founder and Global Co-CEO YT Jia, along with other investors like SIGN Foundation, Binance Labs, Sequoia Capital, IDG, and Circle.
FF now holds approximately 55% of QLGN’s pro forma common stock, and YT Jia holds about 7%, locked up for two years. The investment, first announced on September 19, marks a key step in FF’s “Dual-Flywheel & Dual-Bridge” Eco-Strategy.
YT Jia stated that this investment helps Faraday Future enter a new phase in executing its global eco-strategy linking EAI and crypto, Web2 and Web3, creating value for stockholders and token holders across FF and CXC10. QLGN is expected to rebrand as CXC10 soon, reflecting its new strategic direction around crypto and web3 business.
Faraday Future, founded in 2014, aims to disrupt the automotive industry with user-centric, technology-first smart driving experiences. The FF 91 model embodies its vision for luxury and innovation. FF’s FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation.
Contact: John Schilling, john.schilling@ff.com
Source: Faraday Future
